Lumibird SA (0FRI) AI Stock Analysis

Lumibird SA

(LSE:0FRI)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Steady Revenue GrowthSteady revenue expansion indicates continuing demand for Lumibird’s photonics products across its industrial, defense, and life-science markets. Although growth has moderated, an established growth base can support recurring customer relationships, operating scale, and further investment in differentiated technologies.

Negative Factors

Volatile Free Cash FlowUneven free-cash-flow generation weakens confidence in the durability of reported earnings and can constrain the company’s ability to fund growth internally. The latest low conversion from net income suggests that working-capital movements or capital spending may continue to absorb cash.

Lumibird SA (0FRI) vs. iShares MSCI United Kingdom ETF (EWC)

Market Cap: EUR 527.53M
Dividend Yield: 1.57%
Average Volume (3M): 1,280
Price to Earnings (P/E): 38.2
Beta (1Y): 0.56
Revenue Growth: 8.13%
EPS Growth: 31.36%
Country: UK
Employees: 1,078
Sector: General
Sector Strength: 55
Industry: Hardware, Equipment & Parts

Lumibird SA Business Overview & Revenue Model

Company Description

A global leader, Lumibird S.A. specializes in the development, manufacturing, and distribution of a wide array of laser technologies. Its sophisticated laser products are deployed worldwide across scientific, industrial, and medical sectors. The comp...

Lumibird SA Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

GB:0FRI against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FR:DIM	69Neutral	EUR 21.74B	66.89	7.71%	0.31%	3.90%	22.74%
FR:BIM	61Neutral	EUR 10.69B	23.03	11.01%	1.08%	-3.18%	22.52%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
FR:ALTHE	46Neutral	EUR 51.65M	-6.76	453.10%	―	-16.98%	20.31%
FR:ALMDT	43Neutral	EUR 180.85M	-3.00	271.64%	―	2.16%	-5.26%
FR:ALMKT	41Neutral	EUR 18.94M	1.53	-157.72%	―	3.38%	―

* General Sector Average

Performance Comparison

GB:0FRI and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
GB:0FRI	Lumibird SA	23.95	2.89	13.73%
FR:BIM	bioMerieux SA	90.50	-17.32	-16.06%
FR:ALMKT	MAUNA KEA TECHNOLOGIES	0.10	0.01	6.59%
FR:DIM	Sartorius Stedim Biotech	223.40	23.81	11.93%
FR:ALTHE	Theraclion SA	0.70	-0.04	-5.41%
FR:ALMDT	Median Technologies	3.69	0.71	24.03%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Lumibird SA AI Stock Analysis